Methods of quantifying MicroRNAs for hypoxia research: Classic and next generation

Antioxidants and Redox Signaling

Volumn 21, Issue 8, 2014, Pages 1239-1248

  Radovich, Milan ^a,b   Ragoussis, Jiannis ^c,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

BIOINFORMATICS; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HYPOXIA; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RNA SEQUENCE; CELL HYPOXIA; GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; SEQUENCE ANALYSIS;

CELL HYPOXIA; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; SEQUENCE ANALYSIS, RNA;

EID: 84894615681     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5716     Document Type: Review

References (64)

1. An J, Lai J, Lehman ML, and Nelson CC. miRDeep.: An integrated application tool for miRNA identification from RNA sequencing data. Nucleic Acids Res 41: 727-737, 2013
2. Buermans HP, Ariyurek Y, van Ommen G, den Dunnen JT, and 't Hoen PA. New methods for next generation sequencing based microRNA expression profiling. BMC Genomics 11: 716, 2010
3. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, and Ragoussis J. hsamiR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348, 2008
4. Chan SY and Loscalzo J. MicroRNA-210: A unique and pleiotropic hypoxamir. Cell Cycle 9: 1072-1083, 2010
5. Chan YC, Banerjee J, Choi SY, and Sen CK. miR-210: The master hypoxamir. Microcirculation 19: 215-223, 2012
6. Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A, Wang Y, Kristensen GB, Helland A, Borresen-Dale AL, Giaccia A, Longaker MT, Hastie T, Yang GP, van De Vijver MJ, and Brown PO. Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. PLoS Med 3: E47, 2006
7. Chio CC, Lin JW, Cheng HA, Chiu WT, Wang YH, Wang JJ, Hsing CH, and Chen RM. MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells. Arch Toxicol 87: 459-468, 2013
8. Cicchillitti L, Di Stefano V, Isaia E, Crimaldi L, Fasanaro P, Ambrosino V, Antonini A, Capogrossi MC, Gaetano C, Piaggio G, and Martelli F. Hypoxia-inducible factor 1-Alpha induces miR-210 in normoxic differentiating myoblasts. J Biol Chem 287: 44761-44771, 2012
9. Crosby ME, Kulshreshtha R, Ivan M, and Glazer PM. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 69: 1221-1229, 2009
10. Davis MP, van Dongen S, Abreu-Goodger C, Bartonicek N, and Enright AJ. Kraken: A set of tools for quality control and analysis of high-Throughput sequence data. Methods 63: 41-49, 2013
11. Devlin C, Greco S, Martelli F, and IvanM.miR-210:more than a silent player in hypoxia. IUBMB Life 63: 94-100, 2011
12. Fasanaro P, D"Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, and Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883, 2008
13. Fasanaro P, Greco S, Ivan M, Capogrossi MC, and Martelli F. microRNA: Emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther 125: 92-104, 2010
14. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, and Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998
15. Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, Klijn JG, Wiemer EA, and Martens JW. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci U S A 105: 13021-13026, 2008
16. Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, Homer J, Corbridge R, Cox G, West CM, Ragoussis J, and Harris AL. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 116: 2148-2158, 2010
17. Goya R, Sun MG, Morin RD, Leung G, Ha G, Wiegand KC, Senz J, Crisan A, Marra MA, Hirst M, Huntsman D, Murphy KP, Aparicio S, and Shah SP. SNVMix: Predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 26: 730-736, 2010
18. Grosso S, Doyen J, Parks SK, Bertero T, Paye A, Cardinaud B, Gounon P, Lacas-Gervais S, Noel A, Pouyssegur J, Barbry P, Mazure NM, and Mari B. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis 4: E544, 2013
19. Guimbellot JS, Erickson SW, Mehta T, Wen H, Page GP, Sorscher EJ, and Hong JS. Correlation of microRNA levels during hypoxia with predicted targetmRNAs through genomewide microarray analysis. BMC Med Genomics 2: 15, 2009
20. Hackenberg M, Rodriguez-Ezpeleta N, and Aransay AM. miRanalyzer: An update on the detection and analysis of microRNAs in high-Throughput sequencing experiments. Nucleic Acids Res 39: W132-W138, 2011
21. Hafner M, Landgraf P, Ludwig J, Rice A, Ojo T, Lin C, Holoch D, Lim C, and Tuschl T. Identification of micro-RNAs and other small regulatory RNAs using cDNA library sequencing. Methods 44: 3-12, 2008
22. Huang PJ, Liu YC, Lee CC, Lin WC, Gan RR, Lyu PC, and Tang P. DSAP: Deep-sequencing small RNA analysis pipeline. Nucleic Acids Res 38: W385-W391, 2010
23. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le QT, and Giaccia AJ. Hypoxiainducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 35: 856-867, 2009
24. Ivan M, Harris AL, Martelli F, and Kulshreshtha R. Hypoxia response and microRNAs: No longer two separate worlds. J Cell Mol Med 12: 1426-1431, 2008
25. Jayaprakash AD, Jabado O, Brown BD, and Sachidanandam R. Identification and remediation of biases in the activity of RNA ligases in small-RNA deep sequencing. Nucleic Acids Res 39: E141, 2011
26. Kawano M, Kawazu C, Lizio M, Kawaji H, Carninci P, Suzuki H, and Hayashizaki Y. Reduction of non-insert sequence reads by dimer eliminator LNA oligonucleotide for small RNA deep sequencing. Biotechniques 49: 751-755, 2010
27. Keys DN, Au-Young JK, and Fekete RA. TaqMan array cards in pharmaceutical research. Methods Mol Biol 632: 87-97, 2010
28. Kulshreshtha R, Davuluri RV, Calin GA, and Ivan M. A microRNA component of the hypoxic response. Cell Death Differ 15: 667-671, 2008
29. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, and Ivan M. A microRNA signature of hypoxia. Mol Cell Biol 27: 1859-1867, 2007
30. Lau NC, Lim LP, Weinstein EG, and Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862, 2001
31. Linsen SE, de Wit E, Janssens G, Heater S, Chapman L, Parkin RK, Fritz B, Wyman SK, de Bruijn E, Voest EE, Kuersten S, Tewari M, and Cuppen E. Limitations and possibilities of small RNA digital gene expression profiling. Nat Methods 6: 474-476, 2009
32. Liu CG, Calin GA, Volinia S, and Croce CM. MicroRNA expression profiling using microarrays. Nat Protoc 3: 563-578, 2008
33. Lou YL, Guo F, Liu F, Gao FL, Zhang PQ, Niu X, Guo SC, Yin JH, Wang Y, and Deng ZF. miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Mol Cell Biochem 370: 45-51, 2012
34. McCormick RI, Blick C, Ragoussis J, Schoedel J, Mole DR, Young AC, Selby PJ, Banks RE, and Harris AL. miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. Br J Cancer 108: 1133-1142, 2013
35. Mendell JT and Olson EN. MicroRNAs in stress signaling and human Disease. Cell 148: 1172-1187, 2012
36. Mestdagh P, Feys T, Bernard N, Guenther S, Chen C, Speleman F, and Vandesompele J. High-Throughput stemloop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res 36: E143, 2008
37. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, and Vandesompele J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10: R64, 2009
38. Munafo DB and Robb GB. Optimization of enzymatic reaction conditions for generating representative pools of cDNA from small RNA. RNA 16: 2537-2552, 2010
39. Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, and Myatt L. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 33: 816-823, 2012
40. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L, and Isner JM. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270: 31189-31195, 1995
41. Neely LA, Patel S, Garver J, Gallo M, Hackett M, McLaughlin S, Nadel M, Harris J, Gullans S, and Rooke J. A single-molecule method for the quantitation of micro-RNA gene expression. Nat Methods 3: 41-46, 2006
42. Noman MZ, Buart S, Romero P, Ketari S, Janji B, Mari B, Mami-Chouaib F, and Chouaib S. Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer Res 72: 4629-4641, 2012
43. Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, and Stanbridge EJ. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61: 8924-8929, 2001
44. Peltier HJ and Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852, 2008
45. Puissegur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K, Maurin T, Lebrigand K, Cardinaud B, Hofman V, Fourre S, Magnone V, Ricci JE, Pouyssegur J, Gounon P, Hofman P, Barbry P, and Mari B. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 18: 465-478, 2011
46. Radojicic J, Zaravinos A, Vrekoussis T, Kafousi M, Spandidos DA, and Stathopoulos EN. MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle 10: 507-517, 2011
47. Raymond CK, Roberts BS, Garrett-Engele P, Lim LP, and Johnson JM. Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and shortinterfering RNAs. RNA 11: 1737-1744, 2005
48. Ronen R, Gan I, Modai S, Sukacheov A, Dror G, Halperin E, and Shomron N. miRNAkey: A software for microRNA deep sequencing analysis. Bioinformatics 26: 2615-2616, 2010
49. Rothe F, Ignatiadis M, Chaboteaux C, Haibe-Kains B, Kheddoumi N, Majjaj S, Badran B, Fayyad-Kazan H, Desmedt C, Harris AL, Piccart M, and Sotiriou C. Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One 6: E20980, 2011
50. Sarakul O, Vattanaviboon P, Tanaka Y, Fucharoen S, Abe Y, Svasti S, and Umemura T. Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210. Blood Cells Mol Dis 51: 98-103, 2013
51. Sarkar D, Parkin R, Wyman S, Bendoraite A, Sather C, Delrow J, Godwin AK, Drescher C, Huber W, Gentleman R, and Tewari M. Quality assessment and data analysis for micro-RNA expression arrays. Nucleic Acids Res 37: E17, 2009
52. Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS, and Chen C. Real-Time PCR quantification of precursor and mature microRNA. Methods 44: 31-38, 2008
53. Schmittgen TD and Livak KJ. Analyzing real-Time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008
54. Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, Lim SO, Du Y, Wang Y, Chang WC, Chen CH, Hsu JL, Wu Y, Lam YC, James BP, Liu X, Liu CG, Patel DJ, and Hung MC. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497: 383-387, 2013
55. Stocks MB, Moxon S, Mapleson D, Woolfenden HC, Mohorianu I, Folkes L, Schwach F, Dalmay T, and Moulton V. TheUEAsRNAworkbench: A suite of tools for analysing and visualizing next generation sequencing microRNA and small RNA datasets. Bioinformatics 28: 2059-2061, 2012
56. Viollet S, Fuchs RT, Munafo DB, Zhuang F, and Robb GB. T4 RNA ligase 2 truncated active site mutants: Improved tools for RNA analysis. BMC Biotechnol 11: 72, 2011
57. Voellenkle C, Rooij J, Guffanti A, Brini E, Fasanaro P, Isaia E, Croft L, David M, Capogrossi MC, Moles A, Felsani A, and Martelli F. Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. RNA 18: 472-484, 2012
58. Wang Z, Gerstein M, and Snyder M. RNA-Seq: A revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63, 2009
59. Wong L, Lee K, Russell I, and Chen C. Endogenous controls for real-Time quantitation of miRNA using TaqMan MicroRNA assays. Appl Biosyst Application Note 2007
60. Wu C, So J, Davis-Dusenbery BN, Qi HH, Bloch DB, Shi Y, Lagna G, and Hata A. Hypoxia potentiates microRNAmediated gene silencing through posttranslational modification of Argonaute2. Mol Cell Biol 31: 4760-4774, 2011
61. Wyman SK, Knouf EC, Parkin RK, Fritz BR, Lin DW, Dennis LM, Krouse MA, Webster PJ, and Tewari M. Posttranscriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Res 21: 1450-1461, 2011
62. Zhang Z, Sun H, Dai H, Walsh RM, Imakura M, Schelter J, Burchard J, Dai X, Chang AN, Diaz RL, Marszalek JR, Bartz SR, Carleton M, Cleary MA, Linsley PS, and Grandori C. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8: 2756-2768, 2009
63. Zhong H and Simons JW. Direct comparison of GAPDH, beta-Actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun 259: 523-526, 1999
64. Zhu E, Zhao F, Xu G, Hou H, Zhou L, Li X, Sun Z, and Wu J. mirTools: MicroRNA profiling and discovery based on high-Throughput sequencing. Nucleic Acids Res 38: W392-W397, 2010